PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Review Article

Volume 8 Issue 2

Integrative Pathophysiology: Cellular Structure, Homeostatic Regulation, and Disease Progression Across Organ Systems

Christina Rahm*

August 04, 2026

View PDF

Abstract

The paper provides a comprehensive, systems-based exploration of pathophysiology, beginning with the foundational role of cells as the basic units of life and explaining how disruptions in cellular processes such as growth, replication, differentiation, aging (senescence), and death (apoptosis or necrosis) contribute to disease development. It highlights how cellular structures and organelles support essential functions, and how imbalances at this level can cascade into tissue and organ dysfunction. Central to this discussion is homeostasis, the body’s ability to maintain internal stability through tightly regulated mechanisms involving temperature control, fluid and electrolyte balance, glucose regulation, pH maintenance, and cardiovascular dynamics; when these systems are disrupted, disease can emerge. The paper further explains that most diseases are multifactorial, arising from a combination of genetic predisposition, environmental exposures (such as toxins or pathogens), lifestyle factors (including diet and physical activity), immune dysfunction, hormonal imbalances, and psychosocial stressors. It outlines pathogenesis as the stepwise progression from initial exposure to a causative factor through cellular injury, immune response, inflammation, and eventual clinical manifestation, with outcomes ranging from recovery to chronic disease or death.

Expanding beyond foundational concepts, the paper systematically reviews major organ systems, describing both normal physiology and common disease states. It explains how the cardiovascular system maintains oxygen supply and demand and how imbalances lead to conditions like coronary artery disease, heart failure, and arrhythmias. The respiratory system is detailed in terms of ventilation and gas exchange, with diseases such as asthma, COPD, pneumonia, and pulmonary embolism illustrating different mechanisms of dysfunction. The neurologic system is presented as the control center for body function and behavior, with disorders like stroke, Alzheimer’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis arising from disruptions in neural signaling or structure. Similarly, the gastrointestinal system’s role in digestion and absorption is linked to disorders like GERD, ulcers, inflammatory bowel disease, and cancer. The musculoskeletal system is discussed in terms of structure, movement, and mineral storage, with diseases such as osteoarthritis, rheumatoid arthritis, osteoporosis, and disc herniation affecting mobility and stability.

The paper also examines regulatory and support systems, including the endocrine system’s hormone-driven control of metabolism and growth, with disorders like diabetes, thyroid disease, and PCOS; the renal system’s role in filtration and fluid balance, with conditions such as chronic kidney disease and kidney stones; and the hematologic system’s function in oxygen transport, immunity, and clotting, with disorders like anemia and hemophilia. The immune system is described as a critical defense network, with dysfunction leading to autoimmune diseases, allergies, and chronic inflammation, while infectious diseases are explained through pathogen invasion and immune response. Finally, cancer is presented as a complex, multifactorial disease driven by genetic mutations and environmental influences, characterized by uncontrolled cell growth, invasion, and metastasis. Overall, the paper emphasizes that health and disease are deeply interconnected across systems, and that understanding these relationships is essential for developing effective, personalized approaches to prevention, diagnosis, and treatment.

References

  1. Giacomello M., et al. “The cell biology of mitochondrial membrane dynamics”. Nature Reviews Molecular Cell Biology 21.4 (2020): 204-224.
  2. Cooper G and Adams K. “The Cell: A Molecular Approach”. Oxford University Press (2022).
  3. Miller DV and Revelo MP. “Diagnostic Pathology: Cardiovascular”. Elsevier Health Sciences (2023).
  4. Xiong TY., et al. “Coronaviruses and the cardiovascular system: Acute and long-term implications”. European Heart Journal (2020).
  5. Belzile-Dugas E and Eisenberg MJ. “Radiation-induced cardiovascular disease: Review of an underrecognized pathology”. Journal of the American Heart Association 10.18 (2021): e021686.
  6. Calabrese F., et al. “Pulmonary pathology and COVID-19: Lessons from autopsy. The experience of European Pulmonary Pathologists”. Virchows Archiv 477 (2020): 359-372.
  7. Iturriaga R., et al. “Carotid body chemoreceptors: Physiology, pathology, and implications for health and disease”. Physiological Reviews 101.3 (2021): 1177-1235.
  8. Vandenbunder B., et al. “Static compliance of the respiratory system in COVID-19 related ARDS: An international multicenter study”. Critical Care 25.1 (2021): 1-11.
  9. Holtzman J and Lee H. “Emerging role of extracellular vesicles in the respiratory system”. Experimental & Molecular Medicine 52.6 (2020): 887-895.
  10. Bridwell R, Long B and Gottlieb M. “Neurologic complications of COVID-19”. The American Journal of Emergency Medicine 38.7 (2020): 1549.e3.
  11. Nath A. “Neurologic complications of coronavirus infections”. Neurology (2020).
  12. Abdel-Mannan O., et al. “Neurologic and radiographic findings associated with COVID-19 infection in children”. JAMA Neurology 77.11 (2020): 1440-1445.
  13. Li C., et al. “Current in vitro digestion systems for understanding food digestion in human upper gastrointestinal tract”. Trends in Food Science & Technology 96 (2020): 114-126.14.
  14. Su S., et al. “Involvement of digestive system in COVID-19: Manifestations, pathology, management and challenges”. Therapeutic Advances in Gastroenterology 13 (2020).
  15. Neal-Kluever A., et al. “Physiology of the neonatal gastrointestinal system relevant to the disposition of orally administered medications”. Drug Metabolism and Disposition 47.3 (2019): 296-313.
  16. Nordin M and Hirsch Frankel V. “Basic Biomechanics of the Musculoskeletal System”. Lippincott Williams & Wilkins (2001).
  17. Reese NB. “Muscle and Sensory Testing”. Elsevier Health Sciences (2020).
  18. Blyth FM., et al. “The global burden of musculoskeletal pain: Where to from here?” American Journal of Public Health 109.1 (2019): 35-40.
  19. La Perle KMD. “Endocrine system”. In Pathology of Genetically Engineered and Other Mutant Mice (2021): 355-377.
  20. Neumann AM., et al. “Circadian regulation of endocrine systems”. Autonomic Neuroscience 216 (2019): 1-8.
  21. Knight J. “Endocrine system 1: Overview of the endocrine system and hormones”. Nursing Times 117.5 (2021): 38-42.
  22. Johnson JG and Watson MK. “Diseases of the reptile renal system”. Veterinary Clinics: Exotic Animal Practice 23.1 (2020): 115-129.
  23. Delahunt B., et al. “Grading of renal cell carcinoma”. Histopathology 74.1 (2019): 4-17.
  24. Shehata M., et al. “A multimodal computer-aided diagnostic system for precise identification of renal allograft rejection: Preliminary results”. Medical Physics 47.6 (2020): 2427-2440.
  25. Han D., et al. “Current progress in CAR-T cell therapy for hematological malignancies”. Journal of Cancer 12.2 (2021): 326.
  26. Rahi MS., et al. “Hematologic disorders associated with COVID-19: A review”. Annals of Hematology 100 (2021): 309-320.
  27. Madsen ML., et al. “Aspects of vincristine-induced neuropathy in hematologic malignancies: A systematic review”. Cancer Chemotherapy and Pharmacology 84 (2019): 471-485.
  28. Agbuduwe C and Basu S. “Haematological manifestations of COVID-19: From cytopenia to coagulopathy”. European Journal of Haematology 105.5 (2020): 540-546.
  29. Radakovich N, Nagy M and Nazha A. “Machine learning in haematological malignancies”. The Lancet Haematology 7.7 (2020): e541-e550.
  30. Yoo JY., et al. “Gut microbiota and immune system interactions”. Microorganisms 8.10 (2020): 1587.
  31. Abbott M and Ustoyev Y. “Cancer and the immune system: The history and background of immunotherapy”. Seminars in Oncology Nursing 35.5 (2019).
  32. Maldonado Galdeano C., et al. “Beneficial effects of probiotic consumption on the immune system”. Annals of Nutrition and Metabolism 74.2 (2019): 115-124.
  33. Wu Y., et al. “Nervous system involvement after infection with COVID-19 and other coronaviruses”. Brain, Behavior, and Immunity 87 (2020): 18-22.
  34. Vincent JL., et al. “Prevalence and outcomes of infection among patients in intensive care units in 2017”. JAMA 323.15 (2020): 1478-1487.
  35. Altarawneh HN., et al. “Effects of previous infection and vaccination on symptomatic Omicron infections”. New England Journal of Medicine 387.1 (2022): 21-34.
  36. Cox TR. “The matrix in cancer”. Nature Reviews Cancer 21.4 (2021): 217-238.
  37. Hanahan D. “Hallmarks of cancer: New dimensions”. Cancer Discovery 12.1 (2022): 31-46.
  38. Siegel RL., et al. “Cancer statistics, 2022”. CA: A Cancer Journal for Clinicians 72.1 (2022): 7-33.
  39. Claussnitzer M., et al. “A brief history of human disease genetics”. Nature 577.7789 (2020): 179-189.
  40. Loos RJF and Yeo GSH. “The genetics of obesity: From discovery to biology”. Nature Reviews Genetics 23.2 (2022): 120-133.
  41. Maiese DR., et al. “Current conditions in medical genetics practice”. Genetics in Medicine 21.8 (2019): 1874-1877.